Edesa Biotech Inc - ESG Rating & Company Profile powered by AI
The Disclosure rating covers 17 UN SDGs including: 'Zero Hunger', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'. Other companies in the scoring peer group for Edesa Biotech Inc are shown below. Comprehensive ESG assessment of Edesa Biotech Inc are accessed by registering for free.
Edesa Biotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 5.3, social score of 1.6 and governance score of 4.0.
3.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1132 | Taro Pharmaceutical Industries Ltd | 3.7 | Medium |
| 1132 | Traphaco JSC | 3.7 | Medium |
| 1144 | Edesa Biotech Inc | 3.6 | Medium |
| 1144 | CellSeed Inc | 3.6 | Medium |
| 1144 | Cellectar Biosciences Inc | 3.6 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Edesa Biotech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Edesa Biotech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Edesa Biotech Inc report the average age of the workforce?
Sign up for free to unlockDoes Edesa Biotech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Edesa Biotech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Edesa Biotech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Edesa Biotech Inc offer flexible work?
Sign up for free to unlockDoes Edesa Biotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Edesa Biotech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Edesa Biotech Inc conduct supply chain audits?
Sign up for free to unlockDoes Edesa Biotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Edesa Biotech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Edesa Biotech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Edesa Biotech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Edesa Biotech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Edesa Biotech Inc disclose water use targets?
Sign up for free to unlockDoes Edesa Biotech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Edesa Biotech Inc have a product recall in the last two years?
Sign up for free to unlockDoes Edesa Biotech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Edesa Biotech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Edesa Biotech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Edesa Biotech Inc disclose parental leave metrics?
Sign up for free to unlockDoes Edesa Biotech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Edesa Biotech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Edesa Biotech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Edesa Biotech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Edesa Biotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Edesa Biotech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Edesa Biotech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Edesa Biotech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Edesa Biotech Inc disclose its waste policy?
Sign up for free to unlockDoes Edesa Biotech Inc report according to TCFD requirements?
Sign up for free to unlockDoes Edesa Biotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Edesa Biotech Inc disclose energy use targets?
Sign up for free to unlockDoes Edesa Biotech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Edesa Biotech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Edesa Biotech Inc
These potential risks are based on the size, segment and geographies of the company.
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.